Recombinant expression and in vitro characterisation of active Huwentoxin-IV.

by Isabelle Sermadiras, Jefferson Revell, John E Linley, Alan Sandercock, Peter Ravn
Published 2013-01-01

Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease.

by Carl I Webster, Matthew Burrell, Lise-Lotte Olsson, Susan B Fowler, Sarah Digby, Alan Sandercock, Arjan Snijder, Jan Tebbe, Ulrich Haupts, Joanna Grudzinska, Lutz Jermutus, Christin Andersson
Published 2014-01-01